Koji Murakami Selected Research

Ovarian Neoplasms (Ovarian Cancer)

4/2011	Present and future of FDG-PET/CT in ovarian cancer.
8/2008	Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Murakami Research Topics

Disease

23	Neoplasms (Cancer) 01/2017 - 02/2002
7	Cognitive Dysfunction 07/2019 - 01/2007
7	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2002
7	Insulin Resistance 04/2011 - 01/2003
7	Hepatocellular Carcinoma (Hepatoma) 09/2009 - 02/2002
5	Type 2 Diabetes Mellitus (MODY) 01/2012 - 01/2003
5	Obesity 04/2011 - 06/2003
4	Alzheimer Disease (Alzheimer's Disease) 07/2019 - 01/2016
3	Ischemic Stroke 01/2020 - 01/2012
3	Dementia (Dementias) 06/2017 - 09/2012
3	Inflammation (Inflammations) 02/2016 - 04/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015 - 06/2009
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2013 - 01/2012
3	Infarction (Infarctions) 08/2013 - 01/2012
3	Neoplasm Metastasis (Metastasis) 09/2012 - 02/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 02/2005
3	Dyslipidemias (Dyslipidemia) 05/2008 - 08/2003
2	Neurodevelopmental Disorders 09/2022 - 01/2022
2	Memory Disorders (Memory Loss) 09/2022 - 01/2022
2	COVID-19 09/2022 - 01/2022
2	Body Weight (Weight, Body) 09/2022 - 01/2003
2	Sarcoidosis (Schaumann Disease) 01/2022 - 02/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 04/2017
2	Fever of Unknown Origin 01/2021 - 06/2011
2	Asthma (Bronchial Asthma) 01/2020 - 04/2017
2	Osteoarthritis 01/2018 - 11/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 09/2009
2	Stomach Neoplasms (Stomach Cancer) 12/2016 - 10/2016
2	Lymphatic Metastasis 10/2016 - 06/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 06/2008
2	Ovarian Neoplasms (Ovarian Cancer) 04/2011 - 08/2008
2	Lung Neoplasms (Lung Cancer) 12/2010 - 05/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 04/2007
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2010 - 07/2009
2	Atherosclerosis 03/2010 - 01/2003
2	Liver Diseases (Liver Disease) 05/2008 - 09/2007
2	Prostatic Neoplasms (Prostate Cancer) 03/2006 - 07/2003
1	Hyperuricemia 09/2022
1	Rodent Diseases 01/2022
1	Infections 01/2022
1	Heart Failure 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Melanoma (Melanoma, Malignant) 11/2020

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2003
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 06/2008
5	PPAR alphaIBA 09/2009 - 08/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
4	LipidsIBA 11/2011 - 01/2003
4	Deoxyglucose (2 Deoxy D glucose)IBA 06/2011 - 01/2007
4	Insulin (Novolin)FDA Link 04/2011 - 09/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2007
3	Pharmaceutical PreparationsIBA 01/2019 - 11/2011
3	Therapeutic UsesIBA 11/2017 - 02/2002
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2016 - 01/2016
3	N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamideIBA 08/2013 - 01/2012
3	Messenger RNA (mRNA)IBA 07/2010 - 07/2003
2	TAK-418IBA 09/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 04/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 04/2017
2	Amyloid beta-PeptidesIBA 07/2019 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 04/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2017 - 01/2012
2	Coloring Agents (Dyes)IBA 12/2016 - 10/2016
2	Radioisotopes (Radionuclides)IBA 10/2016 - 12/2008
2	Biological ProductsIBA 04/2016 - 01/2007
2	Monoclonal AntibodiesIBA 09/2015 - 06/2009
2	Cannabinoid Receptor AgonistsIBA 08/2013 - 01/2012
2	Nonesterified Fatty Acids (NEFA)IBA 01/2012 - 03/2010
2	Phosphotransferases (Kinase)IBA 04/2011 - 01/2007
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2010 - 01/2003
2	RetinoidsIBA 01/2009 - 09/2003
2	KRP-101IBA 05/2008 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 07/2003 - 02/2002
2	AdiponectinIBA 06/2003 - 01/2003
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2022
1	Uric Acid (Urate)IBA 09/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	iodofiltic acidIBA 01/2022
1	pentadecanoic acidIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Inosine Monophosphate (IMP)IBA 11/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Connexin 43 (Connexin43)IBA 01/2020
1	Taurine FDA Link 01/2020

Therapy/Procedure

13	Therapeutics 01/2019 - 02/2002
4	Radiotherapy 01/2019 - 04/2005
4	Lymph Node Excision (Lymph Node Dissection) 10/2016 - 06/2009
3	Oral Administration 09/2022 - 02/2016
2	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2018 - 03/2017
2	Intravenous Administration 04/2017 - 02/2002
2	Gastrectomy 12/2016 - 10/2016
2	Drug Therapy (Chemotherapy) 09/2012 - 06/2009
2	Adjuvant Chemotherapy 01/2007 - 07/2005
1	Artificial Respiration (Mechanical Ventilation) 09/2022